Back to results
US 2021/0277071 A1Published application
Hybrid neurotoxins
AssigneeIpsen Biopharm Ltd.
InventorsElena FONFRIA-SUBIROS, David BURGIN
Life of this patent
Estimating the term…
Abstract
The present invention relates to hybrid neurotoxins comprising a clostridial light chain and a selective ganglioside binding moiety and to their use in therapy.
Claims20
A hybrid neurotoxin comprising a clostridial light chain (L) and a selective ganglioside binding moiety, wherein said selective ganglioside binding moiety is not a clostridial HCC or a HC domain.
Dependencies are inferred from the claim text.